Penn Engineering researchers have pioneered a new technology that allows the transfection agents, which are positively charged transporters, to accept antibodies that they could not before.
Penn Engineering researchers have pioneered a new technology that allows the transfection agents, which are positively charged transporters, to accept antibodies that they could not before.